Last reviewed · How we verify
Aescin in Horse Chestnut
At a glance
| Generic name | Aescin in Horse Chestnut |
|---|---|
| Sponsor | Chiang Mai University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and Prevent Recurrence of Acute Internal Hemorrhoids, A Randomized Controlled Trial, A Pilot Study (EARLY_PHASE1)
- The Efficacy of Aescin in Combination With MPFF in the Early Control of Bleeding From Acute Internal Hemorrhoids, A Randomized Controlled Trial (NA)
- Efficacy and Safety of CONAN® Proctological Cream for Treatment of Haemorrhoidal Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aescin in Horse Chestnut CI brief — competitive landscape report
- Aescin in Horse Chestnut updates RSS · CI watch RSS
- Chiang Mai University portfolio CI